CXCR4 and prostate adenocarcinoma: Correlation analyses confirmed results from RF learning by showing a significant co-expression of CXCR4 and immune-related genes within the TCGA database and several independent validation cohorts, especially in prostate (PRAD) and liver cancer (LIHC).